Patients and carers' perspectives of participating in a pilot tailored exercise program during chemoradiotherapy for high grade glioma: A qualitative study.

Georgia K B Halkett, Prue Cormie, Shirley McGough, Eva M Zopf, Daniel A Galvão, Robert U Newton, Anna K Nowak

Journal: European journal of cancer care 2021;30(5):e13453

PMID: 33877719

Abstract

OBJECTIVE

To describe glioblastoma patients' and carers' perspectives of participating in a tailored exercise intervention during chemoradiotherapy.

METHODS

A pilot study was conducted to evaluate if exercise was a feasible and safe therapy in patients with glioblastoma undergoing chemoradiotherapy. Patients received a supervised exercise intervention involving an individualised prescription of moderate-intensity aerobic and resistance exercise twice weekly, performed at the hospital when they attended for treatment. Semi-structured interviews were conducted with participants and their carers. Recordings were analysed using thematic analysis.

RESULTS

19 patients and 15 carers participated. Benefits and challenges of participating in the exercise intervention were described. Benefits included an individually tailored exercise program, improvements in health, regaining a sense of control, interacting with people, keeping active and benefits for carers. Challenges included managing symptoms associated with diagnosis and treatment, juggling treatment and exercise, and difficulties engaging in the program.

CONCLUSION

Patients and carers expressed positive perceptions and experiences of participating in exercise during chemoradiotherapy; however, some challenges were experienced. These results support the quantitative pilot study which demonstrated that supervised exercise is feasible, safe and well tolerated by patients receiving chemoradiotherapy for glioblastoma. Randomised controlled trials now need to be conducted with this population.

© 2021 John Wiley & Sons Ltd.

Address: Curtin School of Nursing, Faculty of Health Sciences, Curtin University, Perth, Western Australia, Australia.; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.; Mary MacKillop Institute for Health Research, Australian Catholic University, Melbourne, Victoria, Australia.; Exercise Medicine Research Institute, Edith Cowan University, Perth, Western Australia, Australia.; School of Human Movement and Nutrition Sciences, University of Queensland, Brisbane, Queensland, Australia.; Department of Medical Oncology, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia.; School of Medicine, University of Western Australia, Perth, Western Australia, Australia.

Link outs

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.